Challenges and Opportunities for the Traceability of (Biological) Medicinal Products

This article provides an overview of the current situation regarding the traceability of medicinal products, with a focus on drug safety and biologics. Limited traceability of biologics, in particular with regard to the batch number, is associated with incomplete recording of exposure information in...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Kevin, Stolk, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153964/
https://www.ncbi.nlm.nih.gov/pubmed/29721822
http://dx.doi.org/10.1007/s40264-018-0678-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153964/
https://www.ncbi.nlm.nih.gov/pubmed/29721822
http://dx.doi.org/10.1007/s40264-018-0678-7

Ejemplares similares